Efficacy and safety of tisotumab vedotin versus investigator's choice of chemotherapy in second-line or third-line recurrent or metastatic cervical cancer (innovaTV 301/ENGOT-cx12/GOG-3057): A global, randomized, open-label, phase III study
医学
肿瘤科
内科学
宫颈癌
化疗
癌症
作者
Brian M. Slomovitz,Antonio González‐Martín,Keiichi Fujiwara,Elsa Kalbacher,Andrea Bagaméri,Leslie M. Randall,Jung‐Yun Lee,Susana Banerjee,Fernando Cotait Maluf,Domenica Lorusso,Kan Yonemori,Els Van Nieuwenhuysen,Luís Manso,Linn Woelber,Anneke M. Westermann,Allan Covens,Elizabeth Whalley,Yiyi Chen,Ibrahima Soumaoro,Ignace Vergote